Resveratrol attenuates tubular injury in diabetic kidney disease by suppressing the ferroptosis-ferritinophagy pathway.
文献摘要
Background Diabetic kidney disease (DKD) is a leading cause of end-stage renal disease, and renal oxidative stress (OS)-mediated tubular injury plays a critical role in its progression. Resveratrol (Res) possesses established antioxidative properties, yet its mechanistic involvement in ferroptosis-ferritinophagy signaling remains unclear. This study investigated the protective effects of Res on renal tubular injury in DKD and explored its regulatory role in the ferroptosis-ferritinophagy pathway. Methods A DKD mouse model was established using unilateral nephrectomy followed by streptozotocin injection. A total of 42 male C57BL/6 N mice were used in this study. Six mice served as the blank control group, and the remaining 36 underwent model induction. The 30 successfully modeled mice were randomly divided into 5 groups (n = 6 per group): the DKD group, the positive control group (perindopril 0.48 mg/kg/d), and the resveratrol (Res) low-, medium-, and high-dose groups (1.0, 2.5, 5.0 mg/kg/d, administered by gavage for 8 weeks). Renal function, oxidative stress markers, and renal tubular injury markers were assessed. Hematoxylin and eosin (H&E) staining, Masson staining, 4-hydroxynonenal (4-HNE) immunofluorescence, and Western blotting (for ferroptosis/ferritinophagy-related proteins) were performed. Results Compared with the Black group, DKD group mice exhibited marked OS, tubular injury, and activation of the ferroptosis-ferritinophagy axis. Res treatment significantly reduced fasting blood glucose, SCr, BUN, 24-hour urinary protein, MDA, Fe²⁺, β2-MG, RBP4, and NGAL levels, while elevating T-SOD and GSH-Px (P Conclusion Resveratrol markedly attenuates renal oxidative stress and tubular injury in DKD. These findings suggest that its renoprotective effects may be mediated through inhibition of the ferroptosis-ferritinophagy pathway, highlighting Res as a promising therapeutic candidate for DKD.